PeptiDream Inc (PPTDF)
9.50
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
PeptiDream Cash from Operations (TTM): 88.53M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 88.53M |
September 30, 2023 | 73.16M |
June 30, 2023 | 67.08M |
March 31, 2023 | 58.01M |
December 31, 2022 | -0.636M |
September 30, 2022 | -9.710M |
June 30, 2022 | 11.54M |
March 31, 2022 | 16.03M |
December 31, 2021 | 60.65M |
September 30, 2021 | 58.42M |
June 30, 2021 | 49.23M |
March 31, 2021 | 57.66M |
December 31, 2020 | 16.23M |
September 30, 2020 | 31.57M |
June 30, 2020 | 32.15M |
March 31, 2020 | 36.27M |
September 30, 2019 | 34.41M |
June 30, 2019 | 40.34M |
March 31, 2019 | 50.54M |
Date | Value |
---|---|
December 31, 2018 | 36.62M |
September 30, 2018 | 31.18M |
June 30, 2018 | 9.276M |
March 31, 2018 | 5.741M |
December 31, 2017 | 2.155M |
September 30, 2017 | 4.353M |
June 30, 2017 | 14.06M |
March 31, 2017 | 9.374M |
December 31, 2016 | 20.33M |
September 30, 2016 | 25.08M |
June 30, 2016 | 13.16M |
March 31, 2016 | 17.68M |
December 31, 2015 | 10.77M |
September 30, 2015 | 7.640M |
June 30, 2015 | 12.14M |
March 31, 2015 | 0.9342M |
December 31, 2014 | 0.7972M |
September 30, 2014 | 1.656M |
June 30, 2014 | 0.7144M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.710M
Minimum
Sep 2022
88.53M
Maximum
Dec 2023
40.05M
Average
38.31M
Median
Cash from Operations (TTM) Benchmarks
Takeda Pharmaceutical Co Ltd | 5.353B |
Nxera Pharma Co Ltd | -37.58M |
Stemcell Holdings Inc | 2.544M |
Healios KK | -20.11M |
AnGes Inc | -- |